Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Bioinformatics

A knowledge graph-guided transcriptomic framework identifies a 20-gene prognostic signature for cervical cancer

  1. 1State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, 830017 China
  2. 2College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, 830017 China

Abstract

Background: Current cervical cancer risk stratification relies on FIGO stage and lymph node status, which fail to capture molecular heterogeneity and leave patients over- or under-treated. Conventional transcriptomic biomarker discovery relies solely on differential expression, yielding thousands of candidates that often lack disease specificity. To address these limitations, we developed a computational framework that integrates knowledge graph (KG) embeddings with transcriptomic differential expression to identify cervical cancer-specific prognostic biomarkers.

Results: Among ten embedding models for prediction of gene-disease associations, ComplEx showed the highest cervical cancer specificity (Top 100 mean Z-score = 4.19, range 3.54–6.71). Intersection of KG-predicted candidates (Z ≥ 1.645, P < 0.05) with DESeq2 differentially expressed genes (adjusted P < 0.05, |log2FoldChange|> 1) identified 468 high-confidence candidate genes. Using a nested cross-validated Top-K weighted risk score approach, a 20-gene prognostic signature was finalized. The signature demonstrated an unbiased nested cross-validated C-index of 0.638 ± 0.057 for Top-K selection, while the apparent full-data C-index was 0.760 (bootstrap 95% CI 0.697–0.812) and the mean time-dependent AUC was 0.795. Multivariable Cox regression confirmed the signature as an independent prognostic factor after adjusting for age and FIGO stage (HR = 1.89 per SD, P < 0.001, C-index = 0.803), with the strongest discrimination in Stage I disease (C-index = 0.796). Also, external validation in GSE52903 showed a consistent but non-significant trend toward survival discrimination (log-rank P = 0.055; HR = 1.30).

Conclusions: This study introduces a Z-score-based specificity framework that integrates knowledge-graph embedding with transcriptomic analysis for cervical cancer biomarker discovery. Unlike conventional KG evaluations that rely solely on link-prediction metrics, the disease-specificity Z-score calibrates each gene against ten control solid tumors to filter pan-cancer noise, thereby enhancing the disease specificity of the transcriptomic analysis. These results support the signature’s hypothesis-generating potential for personalized risk stratification, though prospective validation in independent cohorts with survival endpoints remains essential before clinical application.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12859-026-06577-y.

Related

  1. An Oxidative Stress-Associated Seven-Gene Prognostic Signature in Lung Adenocarcinoma: Integrative Transcriptomic Analysis Across Public Cohorts
    X. Zhou, Z. Le, P. Song +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Longitudinal Transcriptomic Analysis Identifies Persistent Immune-Related Signature Associated With Restrictive Left Ventricular Filling Patterns After Heart Transplantation
    Kosuke Takahari, Tatsuya Shiraki, Hidetaka Kioka +14
    Circulation JournalPeer-reviewedCC BY-NC-NDFull text3 citedSurgery & anaesthesiaJ-STAGE
  3. Integrated single-cell and machine learning analysis identifies an autophagy- and immune-related prognostic signature in adrenocortical carcinoma
    Yuezhou Chen, Shengjie Lai, Sijian Fang +5
    Discover OncologyPeer-reviewedCC BYFull textSurgery & anaesthesiaDOAJ
  4. Integrated Transcriptomic Analysis Identifies a Ferroptosis-Related Gene Signature Underlying Macrophage Heterogeneity and Immune Dysregulation in Rheumatoid Arthritis Synovium
    Houchen Liu, Ruizhuo Zhang
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General medicineCrossref
  5. A kbhb-associated prognostic signature identifies TTLL12 as a promoter of lung adenocarcinoma progression associated with M2 macrophage infiltration.
    Sixuan Wu, Yi Xun, Yiling Jiang +1
    Biology directPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
BibTeX
@article{deng2026knowledge,
  title = {{A knowledge graph-guided transcriptomic framework identifies a 20-gene prognostic signature for cervical cancer}},
  author = {Ziyi Deng and Xuehua Bi and Hanyuan Zhang},
  journal = {BMC Bioinformatics},
  year = {2026},
  month = jul,
  doi = {10.1186/s12859-026-06577-y},
  url = {https://doi.org/10.1186/s12859-026-06577-y},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - A knowledge graph-guided transcriptomic framework identifies a 20-gene prognostic signature for cervical cancer
AU  - Ziyi Deng
AU  - Xuehua Bi
AU  - Hanyuan Zhang
PY  - 2026
DA  - 2026/07/30
JO  - BMC Bioinformatics
DO  - 10.1186/s12859-026-06577-y
UR  - https://doi.org/10.1186/s12859-026-06577-y
AB  - Background: Current cervical cancer risk stratification relies on FIGO stage and lymph node status, which fail to capture molecular heterogeneity and leave patients over- or under-treated. Conventional transcriptomic biomarker discovery relies solely on differential expression, yielding thousands of candidates that often lack disease specificity. To address these limitations, we developed a computational framework that integrates knowledge graph (KG) embeddings with transcriptomic differential expression to identify cervical cancer-specific prognostic biomarkers.  Results: Among ten embedding models for prediction of gene-disease associations, ComplEx showed the highest cervical cancer specificity (Top 100 mean Z-score = 4.19, range 3.54–6.71). Intersection of KG-predicted candidates (Z ≥ 1.645, P < 0.05) with DESeq2 differentially expressed genes (adjusted P < 0.05, |log2FoldChange|> 1) identified 468 high-confidence candidate genes. Using a nested cross-validated Top-K weighted risk score approach, a 20-gene prognostic signature was finalized. The signature demonstrated an unbiased nested cross-validated C-index of 0.638 ± 0.057 for Top-K selection, while the apparent full-data C-index was 0.760 (bootstrap 95% CI 0.697–0.812) and the mean time-dependent AUC was 0.795. Multivariable Cox regression confirmed the signature as an independent prognostic factor after adjusting for age and FIGO stage (HR = 1.89 per SD, P < 0.001, C-index = 0.803), with the strongest discrimination in Stage I disease (C-index = 0.796). Also, external validation in GSE52903 showed a consistent but non-significant trend toward survival discrimination (log-rank P = 0.055; HR = 1.30).  Conclusions: This study introduces a Z-score-based specificity framework that integrates knowledge-graph embedding with transcriptomic analysis for cervical cancer biomarker discovery. Unlike conventional KG evaluations that rely solely on link-prediction metrics, the disease-specificity Z-score calibrates each gene against ten control solid tumors to filter pan-cancer noise, thereby enhancing the disease specificity of the transcriptomic analysis. These results support the signature’s hypothesis-generating potential for personalized risk stratification, though prospective validation in independent cohorts with survival endpoints remains essential before clinical application.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12859-026-06577-y.
SN  - 1471-2105
ER  -